SCHEMBL23917253

SCHEMBL23917253

Nc1ncnc2[nH]nc(-c3cc4cc(Oc5ccccc5)c(F)cc4[nH]3)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.39
PIK3CA P42336 2/20 0.39
PIK3CB P42338 2/20 0.39
PIK3CG P48736 2/20 0.39
PRKDC P78527 2/20 0.39
NUDT14 O95848 1/20 0.38
NUDT5 Q9UKK9 1/20 0.38
RET P07949 5/20 0.37
KDR P35968 5/20 0.36
SRC P12931 2/20 0.36
ABL1 P00519 1/20 0.36
BTK Q06187 3/20 0.36
TNK2 Q07912 3/20 0.35
ITK Q08881 3/20 0.35
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34
PLG P00747 1/20 0.34
PLAU P00749 1/20 0.34
PLAT P00750 1/20 0.34
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16665690 0.96 PIK3CD (0.39) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16665669 0.80 RET (0.35) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL22692856 0.79 ERBB2 (0.50) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16665832 0.79 RET (0.39) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23917226 0.77 NUDT14 (0.55) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL19476287 0.77 RET (0.56) RETKDRSRCABL1ITK
SCHEMBL23917557 0.76 RET (0.39) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16655897 0.76 RET (0.54) PIK3CDNUDT14NUDT5RETKDR
SCHEMBL16665670 0.76 RET (0.35) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL19385334 0.73 LCK (0.47) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB PIK3CD 2/4885PIK3CA 6/4885PIK3CB 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.